Document:

Representative Form of Distribution Agreement

 Exhibit 10.1 
 [FORM] 
 [Name Of Fund Or Trust] 

One Franklin Parkway 
 San Mateo, California 94403-1906 
 Franklin/Templeton Distributors, Inc.

 One Franklin Parkway 
 San Mateo, CA 94403-1906 
  

	Re:	 Distribution Agreement 

 Gentlemen: 
 We, [Name of Fund or Trust], (the
“Fund”), comprise of the series listed on Attachment A (each a “Fund”, and collectively, the “Funds”) are a Delaware statutory trust operating as an open-end management investment company or “mutual fund”,
which is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), and whose shares are registered under the Securities Act of 1933, as amended (the “1933 Act”). We desire to issue one or more series or
classes of our authorized but unissued shares of capital stock or beneficial interest (the “Shares”) to authorized persons in accordance with applicable Federal and State securities laws. The Fund’s Shares may be made available in one
or more separate series, each of which may have one or more classes. 
 You have informed us that your company
is registered as a broker-dealer under the provisions of the Securities Exchange Act of 1934, as amended and that your company is a member of the Financial Industry Regulatory Authority. You have indicated your desire to act as the exclusive selling
agent and distributor for the Shares. We have been authorized to execute and deliver this Distribution Agreement (“Agreement”) to you by a resolution of our Board of Trustees (“Board”) passed at a meeting at which a majority of
Board members, including a majority who are not otherwise interested persons of the Fund and who are not interested persons of our investment adviser, its related organizations or with you or your related organizations, were present and voted in
favor of the said resolution approving this Agreement. 

 1. Appointment of Underwriter. Upon the execution of this Agreement
and in consideration of the agreements on your part herein expressed and upon the terms and conditions set forth herein, we hereby appoint you as the exclusive sales agent for our Shares and agree that we will deliver such Shares as you may sell.
You agree to use your best efforts to promote the sale of Shares, but are not obligated to sell any specific number of Shares. 
 However, the Fund and each series retain the right to make direct sales of its Shares without sales charges consistent with the terms of the then current prospectus and statement of additional information
and applicable law, and to engage in other legally authorized transactions in its Shares which do not involve the sale of Shares to the general public. Such other transactions may include, without limitation, transactions between the Fund or any
series or class and its shareholders only, transactions involving the reorganization of the Fund or any series, and transactions involving the merger or combination of the Fund or any series with another corporation or trust. 

2. Independent Contractor. You will undertake and discharge your obligations hereunder as an independent
contractor and shall have no authority or power to obligate or bind us by your actions, conduct or contracts except that you are authorized to promote the sale of Shares. You may appoint sub-agents or distribute through dealers or otherwise as you
may determine from time to time, but this Agreement shall not be construed as authorizing any dealer or other person to accept orders for sale or repurchase on our behalf or otherwise act as our agent for any purpose. 

3. Offering Price. Shares shall be offered for sale at a price equivalent to the net asset value per share of that
series and class plus any applicable percentage of the public offering price as sales commission or as otherwise set forth in our then current prospectus. On each business day on which the New York Stock Exchange is open for business, we will
furnish you with the net asset value of the Shares of each available series and class which shall be determined in accordance with our then effective prospectus. All Shares will be sold in the manner set forth in our then effective prospectus and
statement of additional information, and in compliance with applicable law. 
 4. Compensation.

 A. Sales Commission. You shall be entitled to charge a sales commission on the sale or redemption, as
appropriate, of each series and class of each Fund’s Shares in the amount of any initial, deferred or contingent deferred sales charge as set forth in our then effective prospectus. You may allow any sub-agents or dealers such commissions or
discounts from and not exceeding the total sales commission as you shall deem advisable, so long as any such commissions or discounts are set forth in our current prospectus to the extent required by the applicable Federal and State securities laws.
You may also make payments to sub-agents or dealers from your own resources, subject to the following conditions: (a) any such payments shall not create any obligation for or recourse against the Fund or any series or class, and (b) the terms and
conditions of any such payments are consistent with our prospectus and applicable 

  
 2 

 
Federal and State securities laws and are disclosed in our prospectus or statement of additional information to the extent such laws may require. 

B. Distribution Plans. You shall also be entitled to compensation for your services as provided in any
Distribution Plan adopted as to any series and class of any Fund’s Shares pursuant to Rule 12b-1 under the 1940 Act. The compensation provided in any such Distribution Plan (a “12b-1 Plan”) may be divided into a distribution fee and a
service fee, as set forth in such Plan and the Fund’s then current prospectus and statement of additional information (“SAI”), each of which is compensation for different services to be rendered to the Fund. Subject to the termination
provisions in a 12b-1 Plan, any distribution fee with respect to the sale of a Share subject to such Plan shall be earned when such Share is sold and shall be payable from time to time as provided in the 12b-1 Plan. The distribution fee payable to
you as provided in any 12b-1 Plan shall be payable without offset, defense or counterclaim (it being understood by the parties hereto that nothing in this sentence shall be deemed a waiver by the Fund of any claim the Fund may have against you).

 C. With respect to the sales commission on the redemption of Shares of each series and class of Fund as
provided in Subsection 4.A. above, we will cause our shareholder services agent (the “Transfer Agent”) to withhold from redemption proceeds payable to holders of the Shares all contingent deferred sales charges properly payable by such
holders in accordance with the terms of our then current prospectuses and statements of additional information (each such sales charge, a “CDSC”). Upon receipt of an order for redemption, the Transfer Agent shall direct our custodian to
transfer such redemption proceeds to a general trust account. We shall then cause the Transfer Agent to pay over to you or your assigns from the general trust account such CDSCs properly payable by such holders as promptly as possible after the
settlement date for each such redemption of Shares. CDSCs shall be payable without offset, defense or counterclaim (it being understood that nothing in this sentence shall be deemed a waiver by us of any claim we may have against you.) You may
direct that the CDSCs payable to you be paid to any other person. 
 5. Terms and Conditions of Sales.
Shares shall be offered for sale only in those jurisdictions where they have been properly registered or are exempt from registration or for which appropriate notice filings have been made, and only to those groups of people which the Board may from
time to time determine to be eligible to purchase such shares. 
 6. Orders and Payment for Shares.
Orders for Shares shall be directed to the Fund’s shareholder services agent, for acceptance on behalf of the Fund. At or prior to the time of delivery of any of our Shares you will pay or cause to be paid to the custodian of the Fund’s
assets, for our account, an amount in cash or other consideration as described from time to time in any then effective Fund prospectus equal to the net asset value of such Shares. Sales of Shares shall be deemed to be made when and where accepted by
the Fund’s shareholder services agent. The Fund’s custodian and shareholder services agent shall be identified in its prospectus or SAI. 
 7. Purchases for Your Own Account. You shall not purchase our Shares for your own account for purposes of resale to the public, but you may purchase Shares for your own

  
 3 

 
investment account upon your assurance, which may be in writing, that the purchase is for investment purposes and that the Shares will not be resold except through redemption by us. 

8. Sale of Shares to Affiliates. You may sell our Shares at net asset value to certain of your and our affiliated
persons pursuant to the applicable provisions of the Federal securities statutes and rules or regulations thereunder (the “Rules and Regulations”), including Rule 22d-1 under the 1940 Act, as amended from time to time. 

9. Allocation of Expenses. We will pay (or enter into arrangements providing that persons other than us shall pay)
the expenses: 
  

	 	(a)	 Of the preparation and typesetting of our audited and certified financial statements to be included in any Post-Effective Amendments
(“Amendments”) to our Registration Statement under the 1933 Act or 1940 Act, including the prospectus, the summary prospectus and SAI included therein; 

 

	 	(b)	 Of the preparation, including legal fees, and typesetting of all Amendments or supplements filed with the Securities and Exchange Commission,
including the copies of the prospectuses, summary prospectuses and SAIs included in the Amendments, other than those necessitated by your (including your affiliates’) activities or Rules and Regulations related to your activities where such
Amendments or supplements result in expenses which we would not otherwise have incurred; 

  

	 	(c)	 Of the preparation, printing, mailing and distribution of any reports or communications which we send to our existing shareholders, including
expenses associated with printing, mailing and distributing annually any updated prospectus, summary prospectus, report or SAI to existing shareholders, other than those necessitated by your (including your affiliates’) activities or Rules and
Regulations related to your activities where such communications result in expenses which we would not otherwise have incurred; 

  

	 	(d)	 Of printing, mailing and distribution of any prospectus or summary prospectus included with the confirmation of any purchase order of Fund shares;

  

	 	(e)	 Of reimbursing the reasonable costs of dealers that elect to “print on demand” any prospectus or summary prospectus included with the
confirmation of any purchase order of Fund shares; and 

  

	 	(f)	 Of filing and other fees to Federal and State securities regulatory authorities necessary to continue offering our Shares.

  
 4 

 You will pay (or enter into arrangements providing that persons other than
you shall pay) the expenses: 
  

	 	(a)	 Of the preparation, including legal fees, typesetting, printing, and distributing (including mailing) of all Amendments and supplements to our
prospectuses, summary prospectuses and SAIs if the Amendment or supplement arises from your (including your affiliates’) activities or Rules and Regulations related to your activities and those expenses would not otherwise have been incurred by
us; 

  

	 	(b)	 Of printing and distributing (including mailing) additional copies, for use by you as sales literature or for other marketing or offering purposes,
of reports, prospectuses, summary prospectuses, SAIs, supplements or other communications, which we have prepared for distribution to our existing shareholders; and 

 

	 	(c)	 Incurred by you in advertising, promoting and selling our Shares. 

We acknowledge that some of the expenses to be borne by you under (b) and (c) as set forth above, may be paid from Rule 12b-1 fees that
you receive from the applicable class of the Fund from time to time. 
 10. Furnishing of Information. We
will furnish to you such information with respect to each series and class of Shares, in such form and signed by such of our officers as you may reasonably request, and we warrant that the statements therein contained, when so signed, will be true
and correct. We will also furnish you with such information and will take such action as you may reasonably request in order to qualify our Shares for sale to the public under the Blue Sky Laws of jurisdictions in which you may wish to offer them.
We will furnish you with annual audited financial statements of our books and accounts certified by independent public accountants, with semi-annual financial statements prepared by us, with registration statements and, from time to time, with such
additional information regarding our financial condition as you may reasonably request. 
 11. Conduct of
Business. Other than our currently effective prospectus, you will not issue any sales material or statements except literature or advertising which conforms to the requirements of Federal and State securities laws and regulations and which have
been filed, where necessary, with the appropriate regulatory authorities. You will furnish us with copies of all such materials prior to their use and no such material shall be published if we shall reasonably and promptly object. 

You shall comply with the applicable Federal and State laws and regulations where our Shares are offered for sale and
conduct your affairs with us and with dealers, brokers or investors in accordance with the Conduct Rules of the National Association of Securities Dealers, Inc. 

  
 5 

 12. Redemption or Repurchase Within Seven Days. If Shares are
tendered to us for redemption or repurchase by us within seven business days after your acceptance of the original purchase order for such Shares, you will immediately refund to us the full sales commission (net of allowances to dealers or brokers)
allowed to you on the original sale, and will promptly, upon receipt thereof, pay to us any refunds from dealers or brokers of the balance of sales commissions reallowed by you. We shall notify you of such tender for redemption within 10 days of the
day on which notice of such tender for redemption is received by us. 
 13. Other Activities. Your
services pursuant to this Agreement shall not be deemed to be exclusive, and you may render similar services and act as an underwriter, distributor or dealer for other investment companies in the offering of their shares. 

14. Term of Agreement. This Agreement shall become effective on the date of its execution, and shall remain in
effect for a period of two (2) years. The Agreement is renewable annually thereafter, with respect to the Fund or, if the Fund has more than one series, with respect to each series, for successive periods not to exceed one year (i) by a vote of (a)
a majority of the outstanding voting securities of the Fund or, if the Fund has more than one series, of each series, or (b) by a vote of the Board, and (ii) by a vote of a majority of the members of the Board who are not parties to the
Agreement or interested persons of any parties to the Agreement (other than as members of the Board), cast in person at a meeting called for the purpose of voting on the Agreement. 

This Agreement may at any time be terminated by the Fund or by any series without the payment of any penalty, (i) either
by vote of the Board or by vote of a majority of the outstanding voting securities of the Fund or any series on 90 days’ written notice to you; or (ii) by you on 90 days’ written notice to the Fund; and shall immediately terminate with
respect to the Fund and each series in the event of its assignment. 
 15. Suspension of Sales. We
reserve the right at all times to suspend or limit the public offering of Shares upon two days’ written notice to you. 
 16. Miscellaneous. This Agreement shall be subject to the laws of the State of California and shall be interpreted and construed to further promote the operation of the Fund as an open-end
investment company. This Agreement shall supersede all Distribution Agreements and Amendments previously in effect between the parties. As used herein, the terms “net asset value,” “offering price,” “investment
company,” “open-end management investment company,” “assignment,” “principal underwriter,” “interested person,” “affiliated person,” and “majority of the outstanding voting securities”
shall have the meanings set forth in the 1933 Act or the 1940 Act and the Rules and Regulations thereunder and the term “assignment” shall have the meaning as set forth in the 1940 Act and the Rules and Regulations thereunder. 

  
 6 

 Nothing herein shall be deemed to protect you against any liability to us or
to our securities holders to which you would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence in the performance of your duties hereunder, or by reason of your reckless disregard of your obligations and duties
hereunder. 
 If the foregoing meets with your approval, please acknowledge your acceptance by signing each of
the enclosed copies, whereupon this will become a binding agreement as of the date set forth below. 
 Very truly yours,

 [NAME OF FUND OR TRUST] 
  

			
	 By:
	 	  

		 	     [NAME]

		 	     [TITLE]

	
	 Accepted:

	
	Franklin/Templeton Distributors, Inc.
		
	 By:
	 	  

		 	     [NAME]

		 	     [TITLE]

 Dated:                      

  
 7Non-Employee Director Fees

 Exhibit 10.2 
 DIRECTOR COMPENSATION 
 (NON-EMPLOYEE DIRECTOR FEES) 

The following sets forth the fees and other payments that directors who are not employees of Franklin Resources, Inc.
(“Franklin”) are entitled to receive as members of the Board of Directors (the “Board”), and the fees and other payments that such non-employee Franklin directors who are also members of the Board of Directors of Fiduciary Trust
Company International (“Fiduciary”) receive from Fiduciary. With respect to service on the Franklin Board, the Franklin Board last approved changes in such compensation structure in October 2010 and December 2010 (effective January 1,
2011). With respect to service on the Fiduciary Board, the Fiduciary Board last approved a change in such compensation structure in December 2006 (effective October 1, 2006). 

Effective January 1, 2011, non-employee Franklin directors are entitled to receive an annual Franklin Board retainer
fee of $85,000, payable quarterly in the amount of $21,250, plus $5,000 for each Franklin Board meeting attended by such director in excess of the five regularly scheduled Franklin Board meetings per year, and an annual equity award valued at
$100,000 (rounded up to the nearest whole share) for approval on the date of each annual organizational meeting of the Franklin Board. 
 Non-employee Franklin directors who serve on Franklin Board committees are paid $1,500 per committee meeting attended. Additionally, Chairpersons of the Franklin Compensation Committee and the Franklin
Corporate Governance Committee receive $1,250 per quarter and the Chairperson of the Franklin Audit Committee receives $2,500 per quarter. 
 Non-employee Franklin directors who are also members of the Board of Directors of Fiduciary receive from Fiduciary an annual board retainer fee of $35,000 (one-fourth of which is paid quarterly), and
an annual committee retainer fee of $5,000 (one-fourth of which is paid quarterly) for service on a Fiduciary board committee.
 In addition, Franklin and Fiduciary reimburse directors for certain expenses incurred in connection with attending Board and committee meetings as well as other related events, including travel, hotel
accommodations, meals and other incidental expenses for the director and his or her spouse accompanying the director in connection with such events. Franklin and Fiduciary may also, from time to time, provide directors and their spouses token gifts
of nominal value. 
 Franklin and Fiduciary also allow directors to defer payment of their directors’ fees,
and to treat the deferred amounts as hypothetical investments in Franklin common stock or Franklin Templeton mutual funds. The terms of any such deferred payment arrangements are set forth in separate documentation between Franklin and the
particular directors in accordance with Franklin’s 2006 Directors Deferred Compensation Plan, as amended and restated.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]